Novavax (NVAX) EBT Margin (2010 - 2026)
Novavax (NVAX) reported EBT Margin of -91.14% for Q2 2026, down 136.06 percentage points from 44.91% a year earlier and down 85.05 percentage points from the prior quarter.
Novavax (NVAX) EBT Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Novavax's EBT Margin came in at -59.28%, down 99.27 percentage points year-over-year; for FY2025, it came in at 39.36%, up 65.25 percentage points from FY2024.
- EBT Margin has a five-year change of +127.30 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at -25.89% in FY2024 (+29.31 pp), -55.20% in FY2023 (-22.22 pp), -32.98% in FY2022 (+116.59 pp) and -149.57% in FY2021 (-61.63 pp).
- Five-year quarterly EBT Margin spans a low of -373.39% in Q4 2021 and a high of 77.98% in Q1 2025.
- Year over year, EBT Margin gained in three of the last eight quarters, with an average year-over-year change of -15.89 percentage points.
- The high point for year-over-year EBT Margin in five years was Q4 2022 (a gain of 321.77 percentage points); the low point was Q1 2023 (a drop of 390.88 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -6.10% (Q1 2026), 12.17% (Q4 2025) and -288.22% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Novavax | 1.78 Bn | -1.23 Bn | 42.45 Mn | -91.14% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -91.14% |
| Mar 31, 2026 | -6.10% |
| Dec 31, 2025 | 12.17% |
| Sep 30, 2025 | -288.22% |
| Jun 30, 2025 | 44.91% |
| Mar 31, 2025 | 77.98% |
| Dec 31, 2024 | -83.32% |
| Sep 30, 2024 | -144.75% |
| Jun 30, 2024 | 39.61% |
| Mar 31, 2024 | -154.80% |
| Dec 31, 2023 | -60.65% |
| Sep 30, 2023 | -70.31% |
| Jun 30, 2023 | 13.63% |
| Mar 31, 2023 | -361.60% |
| Dec 31, 2022 | -51.63% |
| Sep 30, 2022 | -22.62% |
| Jun 30, 2022 | -273.80% |
| Mar 31, 2022 | 29.27% |
| Dec 31, 2021 | -373.39% |
| Sep 30, 2021 | -176.91% |
Novavax EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=NVAX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();